Related Experiment Video
Updated: Sep 12, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Treatment of herpes zoster: recombinant alpha-2a-interferon versus acyclovir and vitamin therapy. Clinical Study
B Yu1
1PUMC Hospital, CAMS, Beijing.
Abstract:
The efficacy of r-interferon alpha 2a (IFM) versus acyclovir (ACV) and vitamin therapy in the treatment of herpes zoster is reported. A total of 305 patients were randomly divided into 3 groups. One million units of IFN were administered i.n. once a day for 6 days in 223 cases, oral ACV 200 mg five times daily for 7 days in 34 cases, and vitamin B12, B1 and B2 therapy at conventional doses for 7-14 days in 48 cases. The results showed that both IFN and ACV could reduce pain in patients with herpes zoster and cut the total duration of symptoms, in comparison with vitamin therapy (P < 0.01). In the IFN group, 45 patients (20.2%) experienced side effects, including mild fever in 35 cases (15.7%) and a slightly depressed leukocyte count or increased serum ALT level (3 cases each). In the ACV group, one complained of discomfort in the gastroenteric tract, and another patient reported lumbodynia.
Insights
Recombinant interferon alpha 2a (IFN) and acyclovir (ACV) effectively reduced pain and symptom duration for herpes zoster patients compared to vitamin therapy. Both treatments showed good efficacy, with manageable side effects.
Area of Science:
- Virology
- Immunology
- Dermatology
Background:
- Herpes zoster, commonly known as shingles, is a viral infection that causes a painful rash.
- Effective treatment options are crucial for managing symptoms and preventing complications.
Purpose of the Study:
- To compare the efficacy of recombinant interferon alpha 2a (IFN) against acyclovir (ACV) and vitamin therapy in treating herpes zoster.
- To evaluate pain reduction and symptom duration in patients receiving different treatments.
Main Methods:
- A randomized controlled trial involving 305 herpes zoster patients.
- Patients were divided into three groups: IFN (1 million units i.n. daily for 6 days), oral ACV (200 mg five times daily for 7 days), and vitamin B12, B1, B2 therapy (conventional doses for 7-14 days).
Main Results:
- Both IFN and ACV significantly reduced pain and shortened symptom duration compared to vitamin therapy (P < 0.01).
- IFN treatment resulted in side effects in 20.2% of patients, including mild fever (15.7%), depressed leukocyte count, or elevated ALT levels.
- ACV treatment had minimal side effects, with one patient reporting gastrointestinal discomfort and another experiencing lumbodynia.
Conclusions:
- Recombinant interferon alpha 2a and acyclovir are effective treatments for herpes zoster, offering significant pain relief and symptom duration reduction.
- IFN and ACV demonstrate superior efficacy over conventional vitamin therapy for herpes zoster management.
- While both treatments are effective, ACV appears to have a slightly better side effect profile.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
08:31Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
Published on: September 20, 2021
Related Concept Videos
DNA Base Pairing
Herpes
Chickenpox
Genital Herpes
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors